Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin’s lymphoma
Author:
Affiliation:
1. Division of Medical Oncology, National Cancer Centre Singapore, Singapore
2. Department of Pharmacy, National Cancer Centre Singapore, Singapore
3. Department of Pharmacy, National University of Singapore, Singapore
Publisher
Informa UK Limited
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2015.1125017
Reference6 articles.
1. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2. PD-1 Blockade with the Monoclonal Antibody Pembrolizumab (MK-3475) in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Preliminary Results from a Phase 1b Study (KEYNOTE-013)
3. Immune checkpoint blockade in hematologic malignancies
4. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis
5. T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma;Open Forum Infectious Diseases;2024-03-31
2. A narrative review of the controversy on the risk of mycobacterial infections with immune checkpoint inhibitor use: does Goldilocks have the answer?;Journal of Thoracic Disease;2024-02
3. Pulmonary Tuberculosis Following Immune Checkpoint Inhibitor Treatment for Recurrent Maxillary Squamous Cell Carcinoma;Cureus;2024-01-29
4. Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention;MedComm;2024-01
5. Nontuberculous Mycobacterial Pulmonary Disease in the Immunocompromised Host;Clinics in Chest Medicine;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3